Sustained-release preparations

Details Sustained-release preparations Sustained-release preparations

2005-02-09

2010-02-16

Tate, Christopher R. (Department: 1654)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Tablets, lozenges, or pills

C514S015800

Reexamination Certificate

active

07662408

ABSTRACT:
A sustained release preparation comprising a combination of a microcapsule which gradually releases a GnRH agonist or a salt thereof for a long term, and a microcapsule which gradually releases a GnRH agonist or a salt thereof for a short term.

REFERENCES:
patent: 4652441 (1987-03-01), Okada et al.
patent: 4711782 (1987-12-01), Okada et al.
patent: 4728721 (1988-03-01), Yamamoto et al.
patent: 4849228 (1989-07-01), Yamamoto et al.
patent: 4917893 (1990-04-01), Okada et al.
patent: 4954298 (1990-09-01), Yamamoto et al.
patent: 5061492 (1991-10-01), Okada et al.
patent: 5330767 (1994-07-01), Yamamoto et al.
patent: 5476663 (1995-12-01), Okada et al.
patent: 5575987 (1996-11-01), Kamei et al.
patent: 5585460 (1996-12-01), Yamada et al.
patent: 5611971 (1997-03-01), Maedara et al.
patent: 5631020 (1997-05-01), Okada et al.
patent: 5631021 (1997-05-01), Okada et al.
patent: 5643607 (1997-07-01), Okada et al.
patent: 5716640 (1998-02-01), Kamei et al.
patent: 5851451 (1998-12-01), Takechi et al.
patent: 5889110 (1999-03-01), Hutchinson
patent: 6036976 (2000-03-01), Takechi et al.
patent: 6045830 (2000-04-01), Igari et al.
patent: 6113943 (2000-09-01), Okada et al.
patent: 6190700 (2001-02-01), Okada et al.
patent: 6419961 (2002-07-01), Igari et al.
patent: 6506410 (2003-01-01), Park et al.
patent: 6699500 (2004-03-01), Okada et al.
patent: 6740634 (2004-05-01), Saikawa et al.
patent: 1 197 208 (2002-04-01), None
patent: 1 330 293 (2003-07-01), None
patent: 1 399 133 (2004-03-01), None
patent: 1 466 596 (2004-10-01), None
patent: 63-267720 (1988-11-01), None
patent: 4-321622 (1992-11-01), None
patent: 9-500645 (1997-01-01), None
patent: 10-231242 (1998-09-01), None
patent: 2003-206240 (2003-07-01), None
patent: WO 95/03052 (1995-02-01), None
patent: WO 01/74392 (2000-07-01), None
patent: WO 00/40259 (2003-07-01), None
patent: WO 2004/000363 (2003-12-01), None
Choi, Seung Ho et al., “Hydrophobic ion pair formation between leuprolide and sodium oleate for sustained release from biodegradable polymeric microspheres”,International Journal of Pharmaceutics, vol. 203, (2000), pp. 193-202.
Korean Drug Insert, “LH-RH Derivative for Monthly Adminstration, Rorelin Depot Injection (leuprorelin acetate 3.75 mg)”, (Sold by Hanmi Corporation; prepared on Mar. 13, 2000, revised on Aug. 13, 2002) with its partial English translation.
English translation of Office Action dated Apr. 10, 2009, issued in corresponding Chinese Application No. 200580010382.5, 8 pages.
Conn.Pm. et al., “Gonadotrophin Hormone-Releasing Hormone and the Analogues thereof,” Chinese Medicine—Fascicule on Synthetic Drugs, Biochemical Drugs, and Preparations, 1992, 13(2):87-89, with partial English translation.
Yan et al., “Review of the medication of benign prostatauxe,” Shanghai Medicine, 1993,12:16-18, with partial English translation.
Zhang et al., “Development in the Hormone Therapy of Endometriosis Patient,” Current Advances in Obstetrics and Gynecology, 1998, 7(4):368-371.
Zhou et al., “Clinical Application of Gonadotrophin Hormone-Releasing Hormone Agonist,” Chinese Journal of Practical Gynecology and Obstetrics, 1999, 15(12):754-756.

Affiliated with

Also associated with

Rating

Sustained-release preparations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sustained-release preparations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained-release preparations will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4230540